BeStock  
Stocks › Biotechnology › INBX

Inhibrx Biosciences INBX

US equityMarket cap rank #3034Biotechnology
$94.56 −$2.43 (-2.51%)
Pre-market · Oct 6, 4:10 am ET · After hours $95.69 +1.20%
Open$97.56
Prev close$96.99
Day range$94.18 – $98.51
Volume207.1K
Market cap$1.39B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / book-26.3x
CheapRich

Near the bottom of its 5-year range · 16th percentile, 5-year average 7.2x

Price / sales1,070.5x
CheapRich

Near the top of its 5-year range · 82nd percentile, 5-year average 660.0x

#5074 of 5147 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$65.81
Price vs. fair value+43.7%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -26.27 – 7.19 16% (cheaper than usual) –
PS 1,070.54 219.17 660.00 82% (pricier than usual) #5074 of 5147 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$65.81
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on INBX.

Leave a comment

Scroll to Top